Race or genetic makeup for hepatitis C virus treatment decisions?
Hepatology
.
2017 Jun;65(6):2124-2125.
doi: 10.1002/hep.29057.
Epub 2017 Apr 18.
Authors
Thomas R O'Brien
1
,
Shyam Kottilil
2
,
Jordan J Feld
3
,
Timothy R Morgan
4
,
Ruth M Pfeiffer
5
Affiliations
1
Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
2
Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD.
3
Toronto Centre for Liver Disease, University of Toronto, Toronto, Canada.
4
VA Long Beach Healthcare System, Long Beach, CA.
5
Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
PMID:
28100007
PMCID:
PMC5444941
DOI:
10.1002/hep.29057
No abstract available
Publication types
Letter
Research Support, N.I.H., Intramural
Comment
MeSH terms
Hepacivirus / genetics*
Hepatitis C / genetics
Hepatitis C, Chronic / virology*
Humans
Racial Groups
Grants and funding
Z01 CP005782-13/Intramural NIH HHS/United States